Ovensa Inc.
Major Drugs - N/A, Canada, CA
Ovensa Inc. Employees
Ovensa Inc. Senior Management
Ovensa Inc. Details
Ovensa is a Canadian preclinical stage company committed to advance its siRNA lead candidate silencing galectin-1 overexpression in the tumor microenvironment to improve therapeutic outcomes of an immuno-oncology anti-PD-1 checkpoint inhibitor as a combination therapy in head & neck cancer.The company is also advancing its collaboration programs with pharmaceutical companies to develop precision and combination medicines through its proprietary TRIOZAN™ Platform for specific indications.
Website:
ovensa.com
Employees:
10 - 19
HQ:
N/A
Location:
N/A, Canada, CA
Revenue:
1 - 2.5 Million
Ovensa Inc. Technologies
Email Providers
Outlook
CMS
WordPress.org
Other
Mobile Friendly